A biotechnology venture fund completed a $6 million Series AA investment in a privately held pharmaceutical company. Our firm represented the venture fund in the transaction.
A biotechnology venture fund completed a $6 million Series AA investment in a privately held pharmaceutical company. Our firm represented the venture fund in the transaction.